Bluejay Diagnostics (BJDX) Operating Expenses (2020 - 2026)

Bluejay Diagnostics has disclosed Operating Expenses across 7 years of filings, most recently posting $2.3 million for Q2 2026.

• In Q2 2026, Operating Expenses rose 18.32% year-over-year to $2.3 million; the TTM figure through Jun 2026 stood at $7.4 million (up 9.61% YoY), while the FY2025 annual figure was $7.0 million, down 3.02% from the prior year.
• Operating Expenses came in at $2.3 million for Q2 2026 at Bluejay Diagnostics, up from $1.9 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $2.9 million in Q2 2023 to a low of $1.4 million in Q3 2024.
• Average Operating Expenses over 5 years is $2.1 million, with a median of $2.1 million recorded in 2022.
• Year-over-year, Operating Expenses surged 786.91% in 2022 and slumped 41.84% in 2024.
• Over 5 years, Operating Expenses stood at $2.5 million in 2022, then retreated by 2.73% to $2.4 million in 2023, then plunged by 37.8% to $1.5 million in 2024, then retreated by 1.54% to $1.5 million in 2025, then surged by 60.71% to $2.3 million in 2026.
• Per Business Quant data, the three most recent Operating Expenses figures were $2.3 million in Q2 2026, $1.9 million in Q1 2026, and $1.5 million in Q4 2025.